Niall Tebbutt

9PUBLICATIONS
89CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 24, 2026
Triple M Syndrome Associated With Concurrent Durvalumab and Olaparib Therapy in Metastatic Cholangiocarcinoma: A Case Report.

|May 05, 2025
Characteristics of Patients and Prognostic Factors Across Treatment Lines in Metastatic Colorectal Cancer: An Analysis From the Aide et Recherche en Cancérologie Digestive Database.

Jean-Baptiste Bachet, Aimery de Gramont, Morteza Raeisi

|Oct 04, 2024
INTEGRATE IIa Phase III Study: Regorafenib for Refractory Advanced Gastric Cancer.

Nick Pavlakis, Kohei Shitara, Katrin Sjoquist

|Sep 12, 2023
The prognostic impact of peritoneal tumour DNA in gastrointestinal and gynaecological malignancies: a systematic review.

Zexi Allan, Sasha Witts, Jeanne Tie

|Jan 13, 2023
A Phase Ib/II Trial of Combined BRAF and EGFR Inhibition in BRAF V600E Positive Metastatic Colorectal Cancer and Other Cancers: The EVICT (Erlotinib and Vemurafenib In Combination Trial) Study.

Lavinia Tan, Ben Tran, Jeanne Tie

|Nov 07, 2022
Genotype-Tailored ERK/MAPK Pathway and HDAC Inhibition Rewires the Apoptotic Rheostat to Trigger Colorectal Cancer Cell Death.

Laura J Jenkins, Ian Y Luk, W Douglas Fairlie

Pageof 2

Frequent Collaborators

3 joint publications

Richard M Goldberg

3 joint publications

Richard Adams

3 joint publications

Aimery deGramont

3 joint publications

Eric Van Cutsem